Skin microcirculation and echocardiographic and biochemical indices of left ventricular dysfunction in non-diabetic patients with heart failure

Cardiology Journal

Volumn 18, Issue 3, 2011, Pages 270-276

  Dubiel, Marzena ^a   Królczyk, Jarosław ^b   Gasowski, Jerzy ^a   Grodzicki, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Ejection fraction; Heart failure; Microcirculation

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; SKIN BLOOD FLOW; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SKIN; STROKE VOLUME; VASCULAR DISEASES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79959293475     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Stefanec T. Endothelial apoptosis. Could it have a role in the pathogenesis and treatment of disease. Chest, 2000; 117: 841-854.
2. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005; 26: 1115-1140.
3. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003; 21: 1011-1053.
4. Duprez D, De Buyzere M, Dhondt E, Clement DL. Impaired microcirculation in heart failure. Int J Microcirc Clin Exp, 1996; 16: 137-142.
5. Houben AJHM, Beljaars JH, Hofstra L, Kroon AA, De Leeuw PW. Microvascular abnormalities in chronic heart failure: A cross--sectional analysis. Microcirculation, 2003; 10: 471-478.
6. Wroblewski H, Nørgaard T, Haunsø S, Kastrup J. Microvascular distensibility in two different vascular beds in idiopathic dilated cardiomyopathy. Am J Physiol, 1995; 269: 1973-1980.
7. De Boer RA, Pinto YM, Van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: The role of microvascular growth abnormalities. Microcirculation, 2003; 10: 113-126.
8. Bergström J, Lindholm B. Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis, 1998; 32: 834-841.
9. Chong AY, Freestone B, Patel J et al. Endothelial activation, dysfunction, and damage in congestive heart failure and relation to brain natriuretic peptide and outcomes. Am J Cardiol, 2006; 97: 671-675.
10. Andersson SE, Edvinsson ML, Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: Association with inflammation. Clin Sci, 2003; 105: 699-707.
11. Feihl F, Liaudet L, Waeber B, Levy BY. Hypertension: A disease of the microcirculation? Hypertension, 2006; 48: 1012-1017.
12. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci, 2006; 27: 503-508.
13. Deanfield J, Donald A, Ferri C et al. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial factors of the European Society of Hypertension. J Hypertens, 2005; 23: 7-17.
14. Andreassen AK, Kirkeboen KA, Gullestad L, Simonsen S, Kvernebo K. Effect of heart transplantation on impaired peripheral microvascular perfusion and reactivity in congestive heart failure. Int J Cardiol, 1998; 65: 33-40.
15. Sorensen VB, Wroblewski H, Galatius S, Nørgaard T, Haunsø S, Kastrup J. Skin microvascular distensibility and structural microangiopathy in idiopathic dilated cardiomyopathy and after heart transplantation. Microvasc Res, 1999; 57: 44-51.
16. Kubli S, Feihl F, Waeber B. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilatation. Clin Pharmacol Ther, 2001; 69: 238-244.
17. Rakusan K, Cicutti N, Maurin A, Guez D, Schiavi P. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Microvasc Res, 2000; 59: 243-254.
18. Kovasc I, Toth J, Tarjan J, Koller A. Correlation of flow mediated dilatation with inflammatory markers in patients with impaired cardiac function. Beneficial effect of inhibition of ACEI. Eur J Heart Fail, 2006; 8: 451-459.
19. Galatius S, Wroblewski H, Sørensen V, Haunsø S, Nørgaard T, Kastrup J. Reversal of peripheral microvascular dysfunction during long--term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure. J Card Fail, 1999; 5: 17-24.
20. Holm T, Andreassen AK, Ueland T et al. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male transplant recipients. Am J Cardiol, 2001; 87: 815-817.
21. Haak E, Abletshauser C, Weber S et al. Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia. Atherosclerosis, 2001;155: 395-401.